Clinical research leader True North Clinical Research Inc., recently announced that it has merged with IACT LMC Manna Research, significantly expanding the latter organization’s services in central nervous system (CNS) disorders.
Halifax, Nova Scotia-based True North is a two-site network of CNS-focused clinical research sites, known throughout North America for its work in CNS studies. Launched in 2006 to conduct clinical research trials in Alzheimer’s Dementia, the network is involved in a wide variety of CNS disorder trials, such as Mild Cognitive Impairment (MCI), Huntington’s, Depression and ADHD.
IACT LMC Manna Research — launched in November as part of a strategic alliance between U.S.-based IACT Health and Canada-based LMC Manna Research — is one of the largest consolidated research networks in North America, with more than 40 sites, access to over 1.6 million patients, and more than 150 active investigators.
“The merger with IACT LMC Manna Research is a clear win for both groups,” said Dr. Mark Johnston, founder and Medical Director of True North, adding that, being based in a smaller market, his network has been able to successfully out-recruit other centers by being innovative, patient-focused, and attentive to quality. “IACT LMC Manna Research has sites stretching across North America, and covers diverse therapeutic areas such as Endocrine, Cardiovascular, Women’s Health, and Vaccines. By joining forces, True North brings expertise in an area poised for key growth. We’re excited to bring our CNS expertise to existing sites, where we plan to launch Alzheimer’s Dementia trials in the new year.”
“Just as important, IACT LMC Manna Research will bring its areas of expertise to Nova Scotia, and we plan to start Vaccine and Women’s Health trials at our Nova Scotia sites in early 2022,” Johnston added. “It’s eminently clear that each of the companies complement each other in terms of geography and therapeutic areas. In joining forces, the teams are excited to bring more opportunities for clinical research to patients throughout North America.”
“We are thrilled to join forces with such a highly-qualified and reputable research organization that brings such deep experience and a proven track record in the growing therapeutic area of CNS research,” said Dr. Jeff Kingsley, CEO of IACT LMC Manna Research.
“IACT LMC Manna Research is excited about the opportunity to work with True North’s talented team, who share our approach to integrated research sites and systems, and place strong emphasis on quality and patient experience,” said Karri Venn, COO of IACT LMC Manna Research. “Together, we will offer sponsors and CROs multi-site, multi-provincial and stateside access to CNS-focused clinical research centers and experienced investigators.”